Durable Results with In Situ Graft Repair of Ruptured Salmonella Aneurysm in a Patient with Autoimmune Deficiency Syndrome

Patrick C. Thompson; Lisa Wang; Jesse Columbo; Andres Schanzer; William P. Robinson

doi:10.1055/s-0035-1556840

International Journal of Angiology, Inhaltsverzeichnis

Int J Angiol 2016; 25(05): e131-e134
DOI: 10.1055/s-0035-1556840

Case Report

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Durable Results with In Situ Graft Repair of Ruptured Salmonella Aneurysm in a Patient with Autoimmune Deficiency Syndrome

Patrick C. Thompson

¹Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

,

Lisa Wang

¹Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

,

Jesse Columbo

¹Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

,

Andres Schanzer

¹Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

,

William P. Robinson

¹Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

› Institutsangaben

Abstract

We describe a case of a 42-year-old male patient with advanced autoimmune deficiency syndrome (AIDS) (CD4 count of 16 cells/mm³) found to have a ruptured infected infrarenal aortic aneurysm. Emergent in situ repair was performed with a Hemashield Dacron graft (Boston Scientific, Natick, MA). Aortic tissue cultures grew group D Salmonella. Patient was placed initially on intravenous ciprofloxacin followed by lifelong oral levofloxacin and trimethoprim. Over 2 years following repair, he remains asymptomatic, with repair intact and no recurrent infection. This case is the first reported successful long-term repair of a ruptured salmonella infected abdominal aortic aneurysm in the setting of advanced AIDS.

Keywords

abdominal aortic aneurysm - mycotic aneurysm - AIDS - infection - ruptured aneurysm - in situ repair - salmonella

Volltext

Referenzen

References
1 Weis-Müller BT, Rascanu C, Sagban A, Grabitz K, Godehardt E, Sandmann W. Single-center experience with open surgical treatment of 36 infected aneurysms of the thoracic, thoracoabdominal, and abdominal aorta. Ann Vasc Surg 2011; 25 (8) 1020-1025
2 Leo PJ, Pearl J, Tsang W. Mycotic aneurysm: a diagnostic challenge. Am J Emerg Med 1996; 14 (1) 70-73
3 Woon CYL, Sebastian MG, Tay KH, Tan SG. Extra-anatomic revascularization and aortic exclusion for mycotic aneurysms of the infrarenal aorta and iliac arteries in an Asian population. Am J Surg 2008; 195 (1) 66-72
4 Borris LC, Nøhr M, Petersen K. Rapid growth and early rupture of a primary mycotic aneurysm of the abdominal aorta. Eur J Vasc Surg 1989; 3 (5) 461-463
5 Robinson WP, Schanzer A, Li Y , et al. Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg 2013; 57 (2) 354-361
6 Dubois M, Daenens K, Houthoofd S, Peetermans WE, Fourneau I. Treatment of mycotic aneurysms with involvement of the abdominal aorta: single-centre experience in 44 consecutive cases. Eur J Vasc Endovasc Surg 2010; 40 (4) 450-456
7 Oderich GS, Panneton JM, Bower TC , et al. Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results. J Vasc Surg 2001; 34 (5) 900-908
8 Cartery C, Astudillo L, Deelchand A , et al. Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann Vasc Surg 2011; 25 (2) 266.e9-266.e16
9 Hsu RB, Chen RJ, Wang SS, Chu SH. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg 2004; 40 (1) 30-35
10 Lee CH, Hsieh HC, Ko PJ, Li HJ, Kao TC, Yu SY. In situ versus extra-anatomic reconstruction for primary infected infrarenal abdominal aortic aneurysms. J Vasc Surg 2011; 54 (1) 64-70
11 Uchida N, Katayama A, Tamura K, Miwa S, Masatsugu K, Sueda T. In situ replacement for mycotic aneurysms on the thoracic and abdominal aorta using rifampicin-bonded grafting and omental pedicle grafting. Ann Thorac Surg 2012; 93 (2) 438-442
12 Koshiko S, Sasajima T, Muraki S , et al. Limitations in the use of rifampicin-gelatin grafts against virulent organisms. J Vasc Surg 2002; 35 (4) 779-785
13 Kritpracha B, Premprabha D, Sungsiri J, Tantarattanapong W, Rookkapan S, Juntarapatin P. Endovascular therapy for infected aortic aneurysms. Paper presented at: the 2010 Vascular Annual Meeting of the Society for Vascular Surgery; June 10–13, 2010; Boston, MA
14 Wu SW, Chang HR, Tsao SM, Wu YL, Yao CC, Lian JD. A Salmonella infection complicated with suppurative thyroiditis and ruptured aortic mycotic aneurysm in a renal transplant recipient. Transplant Proc 2008; 40 (10) 3759-3763
15 Thawait SK, Akay A, Jhirad RH, El-Daher N. Group B streptococcus mycotic aneurysm of the abdominal aorta: report of a case and review of the literature. Yale J Biol Med 2012; 85 (1) 97-104
16 Dupont JR, Bonavita JA, DiGiovanni RJ, Spector HB, Nelson SC. Acquired immunodeficiency syndrome and mycotic abdominal aortic aneurysms: a new challenge? Report of a case. J Vasc Surg 1989; 10 (3) 254-257
17 Pasic M, Carrel T, Vogt M, von Segesser L, Turina M. Treatment of mycotic aneurysm of the aorta and its branches: the location determines the operative technique. Eur J Vasc Surg 1992; 6 (4) 419-423